Risk factors for new thromboembolic stroke in patients ≤62 years of age with chronic atrial fibrillation

American Journal of Cardiology

Volumn 82, Issue 1, 1998, Pages 119-121

  Aronow, Wilbert S ^a   Ahn, Chul ^b   Kronzon, Itzhak ^b   Gutstein, Hal ^b  

^a HEBREW HOSPITAL HOME   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032127763     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00247-1     Document Type: Article

References (16)

1. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 323:1990;1505-1511.
2. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke the Framingham Study . Stroke. 22:1991;983-988.
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 154:1994;1449-1457.
4. Aronow W.S., Ahn C., Mercando A.D., Epstein S., Gutstein H. Correlation of paroxysmal supraventricular tachycardia, atrial fibrillation, and sinus rhythm with incidences of new thromboembolic stroke in 1476 old-old patients. Aging Clin Exp Res. 8:1996;32-34.
5. Aronow W.S., Gutstein H., Hsieh F.Y. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol. 63:1989;366-367.
6. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med. 116:1992;6-12.
7. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med. 116:1992;1-5.
8. Peterson P., Kastrup J., Helweg-Larsen S., Boysen G., Godtfredsen J. Risk factors for thromboembolic complications in chronic atrial fibrillation. Arch Intern Med. 150:1990;819-821.
9. Aronow W.S., Koenigsberg M., Kronzon I., Gutstein H. Association of mitral annular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients. Am J Cardiol. 65:1990;1511-1512.
10. Aronow W.S., Ahn C., Gutstein H. Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc. 44:1996;521-523.
11. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 342:1993;1255-1262.
12. Aronow W.S., Ahn C., Kronzon I. Prevalence of echocardiographic findings in 554 men and in 1,243 women aged >60 years in a long-term health care facility. Am J Cardiol. 79:1997;379-380.
13. Aronow W.S., Ahn C., Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol. 66:1990;1257-1259.
14. Master A.M., Lasser R.P., Beckman G. Tables of average weight and height of Americans aged 65 to 94 years relationship of weight and height to survival . JAMA. 172:1960;658-662.
15. Henry W.L., Gardin J.M., Ware J.H. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 62:1980;1054-1061.
16. Devereux R.B., Casale P.N., Kligfield P., Eisenberg R.R., Miller D., Camp E., Alonso D.R. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation, and dilated cardiomyopathy. Am J Cardiol. 57:1986;1388-1393.